Your session is about to expire
← Back to Search
BMS-986165 for Ulcerative Colitis
Study Summary
This trial will test if an experimental drug is safe and effective for people with moderate to severe ulcerative colitis.
- Ulcerative Colitis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 3 trial • 220 Patients • NCT04167462Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is BMS-986165 a reliable treatment option with minimal risk?
"BMS-986165 scores a 2 on our Power scale due to the preliminary safety data, but there is no evidence of efficacy yet."
Are participants still being welcomed for this experiment?
"At present, this particular clinical trial is not enrolling any more patients. It was initially posted on July 1st 2019 and last edited November 27th 2022. If you are searching for other studies related to ulcer or BMS-986165, there are 408 trials recruiting participants afflicted with the former condition and 11 trials actively seeking individuals for the latter medication."
Could you elucidate on other investigations which have utilized BMS-986165?
"BMS-986165 was initially tested in 2018 at Gastromed and has since accrued a total of 18,353 completed trials. Currently, 11 more studies are actively enrolling participants with the majority hosted by medical centres in Las Vegas, Nevada."
Are any medical centers in North America currently conducting this research?
"This medical research study is being conducted across 41 different sites. Examples of locations that are participating include Local Institution - 0002 in Las Vegas, Local Institution- 0048 in New Port Richey and Local Institution - 0121 in Glenview as well as numerous other facilities."
Who meets the criteria for enrollment in this experiment?
"This clinical trial is currently accepting applicants between the ages of 18 and 80 who have been diagnosed with ulcer. 131 participants are expected to be recruited for this opportunity."
How many volunteers are engaged in this clinical experiment?
"This trial is no longer open to new participants as it was last modified on November 27th 2022. However, if you're seeking other clinical studies related to ulcers or BMS-986165, there are 408 and 11 such experiments accepting enrollees respectively."
Does this experimental protocol specify any age restrictions?
"Eligible participants for this trial must have an age range between 18 to 80. Patients younger than 18 can seek out the 71 clinical trials tailored to their demographic, while seniors over 65 have access to 357 studies that meet their criteria."
Is this a pioneering research project?
"Investigated since 2018, BMS-986165 has been developed under the aegis of Bristol-Myers Squibb. After 240 participants participated in its initial clinical trial in 2018, the drug was approved for Phase 2 testing. Currently, 36 nations and 401 cities are hosting 11 active trials involving this compound."
Share this study with friends
Copy Link
Messenger